Contents:

SECTION 1: Airway Management - Current Controversies

1. Can Sellick Maneuver Prevent Pulmonary Aspiration in the Critically Ill?

2. Etomidate vs. Ketamine - What Should We Use for Intubation in ICU

SECTION 2: Extracorporeal Therapies

3. Plasmapheresis: Current Indications in the Critically Ill

4. Are Super High-Flux Membrane Dialyzers the Future of RRT?

5. What is New in Artificial Liver Support Systems?

SECTION 3: Sepsis

6. Back to the Genes: Does Genetic Polymorphism have a Role in Sepsis Management?

7. Controversies in Surviving Sepsis Guidelines 2021

8. Are We Back to Square One? Early Fluids vs. Vasopreressors in Septic Shock

9. Have We Achieved Balance in Fluid Therapy: Balanced Salt Solutions vs. Normal Saline?

SECTION 4: Biomarkers

10. Novel Biomarkers During Circulatory Shock

11. Biomarkers in Acute Intoxications

12. Do Biomarkers have a Role in Patients with Primary Brain Injury?

13. Utility of MicroRNAs in the Critically Ill

14. Neutrophil to Lymphocyte Ratio in Critically Ill: A Simple but Useful Marker?

15. Do Vocal Biomarkers have a Future in Critical Care

SECTION 5: COVID-19 Pandemic: Lessons Learnt

16. Awake Prone Positioning in ARDS?

17. Immunomodulators for COVID-19 Therapy

18. Has Critical Care Telemedicine Come of Age During the Pandemic

19. Post-COVID Conditions (PCCs) or Long COVID Syndrome

20. Capacity Building During Large Scale Disasters

21. Clearing the Air: Alternatives to Isolation Rooms

SECTION 6: Mechanical Ventilation

22. Revisiting Exogenous Surfactant Therapy in Acute Lung Injury and ARDS

23. Mechanical Power

24. Volumetric Capnography in 2022

25. Metabolic Alkalosis in Critical Care: A Classical and Physicochemical Approach

26. Oxygen Revisited

SECTION 7

28. High-flow Nasal Cannula: Beyond a COVID-19 Therapy

29. Cefiderocol

30. Newer Fluoroquinolones: Levonadifloxacin, Delafloxacin and Lascufloxacin

31. Newer Combinations of B-Lactam/B-Lactamase

32. Newer Tetracyclines - Eravacycline and Omadacycline

33. Plazomicin: A New Aminoglycoside

34. Lefamulin: A Pleuromutilin Antibiotic

35. Pretomanid for Antitubercular Therapy

36. Contezolid Acefosamil: A New Oxazolidinone

37. Solithromycin and Nafithromycin: The New Macrolides

38. Benapenem and Sulopenem

39. The Dsb (Disulfide bond)

40. Antivirulence Strategies: The Future of Antibacterial Therapy

41. Alternatives to Conventional Antibacterials: Use of Nanomaterials

42. Newer Treatment Approach to Clostridioides Difficile - Fidaxomicin and Bezlotoxumab

43. Recent Advances for Immunotherapies Against Infectious Disease

SECTION 8: What's New Elsewhere?

44. Risk Scoring Systems in Upper Gastrointestinal Bleed

45. Has Hypotension Prediction Index Come of Age

46. Postintensive Care Syndrome and Postintensive Care Syndrome-Family

47. Closed-Loop Hemodynamic Resuscitation In Shock

48. Is Electrical Impedance Tomography Finally Here to Stay

49. Cardiac Output Measurement: Capnodynamic Method and Auto VTI Tool

50. What's New in Glucose Management Technologies for the Critically-ill

51. Vitamins and Trace Element Supplementation for Critically Ill Patients in 2022

Index